{"disease":{"id":"gonadal-disorders","name":"gonadal disorders"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00341458","title":"Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics","phase":"","overall_status":"COMPLETED","enrollment_count":6086,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03562897","title":"Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Catalysis SL","has_results":false},{"nct_id":"NCT02248701","title":"Testosterone Plus Finasteride Treatment After Spinal Cord Injury","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":33,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT04556071","title":"Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":32,"lead_sponsor_name":"Xiaoxiang Chen","has_results":false},{"nct_id":"NCT04189406","title":"Turner Syndrome Minipuberty Study","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT04460872","title":"Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":21,"lead_sponsor_name":"North Florida Foundation for Research and Education","has_results":false},{"nct_id":"NCT03335254","title":"A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"TesoRx Pharma, LLC","has_results":true},{"nct_id":"NCT03403777","title":"Avelumab in Refractory Testicular Germ Cell Cancer.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"National Cancer Institute, Slovakia","has_results":false},{"nct_id":"NCT05048654","title":"A Novel Ovarian Reserve Monitoring Algorithm for Patients at Risk of Ovarian Injury From Gonadotoxic Therapy","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Colorado, Denver","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}